Early Sitting Intervention Outcomes in Ischemic Stroke Patients

Data from the SEVEL randomized controlled trial includes results from 138 ischemic stroke patients. The study compared early versus progressive sitting procedures, measuring outcomes like the modified Rankin score at 3 months and prevalence of medical complications. It was conducted by Fanny E. Herisson and published in 2020.

Use Cases

• Analyze the proportion of patients with a modified Rankin score [0–2] at 3 months post stroke between early-sitting and progressively-sitting groups.
• Compare the prevalence of medical complications and length of hospital stay across the two intervention arms.
• Assess patient tolerance to the sitting procedure as a secondary outcome measure in acute stroke rehabilitation.

Strengths

• Data originates from a prospective multicenter randomized controlled trial with a clinical trial registration (NCT01573299).
• Includes results from 138 analyzed patients, split into two intervention groups (63 early-sitting, 75 progressively-sitting).
• Primary and secondary outcome measures are clearly defined, including the modified Rankin score and medical complications.

Limitations

• The study had a slow enrollment, resulting in fewer patients than anticipated and a realized statistical power of only 37% to detect effects.
• The primary outcome assessment was not blinded, introducing potential bias.
• The sample size of 138 patients limits the detection of effect sizes smaller than +/- 15%.

Provenance

Source

Dryad, from the SEVEL randomized controlled trial.

Collection Method

Prospective multicenter randomized controlled trial comparing two sitting procedures at the acute phase of ischemic stroke.

Time Range

Covers the acute phase of ischemic stroke and 3-month follow-up period.

Freshness

Last updated on 2020-06-24.

Geography

Multicenter study; specific locations not provided.